Our system is currently under heavy load due to increased usage. We're actively working on upgrades to improve performance. Thank you for your patience.
2007
DOI: 10.1159/000100406
|View full text |Cite
|
Sign up to set email alerts
|

A model for genetic complementation controlling the chromosomal abnormalities and loss of heterozygosity formation in cancer

Abstract: The relationship between the apparently random chromosomal changes found in aneuploidy and the genetic instability driving the progression of cancer is not clear. We report a test of the hypothesis that aneuploid chromosomal abnormalities might be selected to preserve cell-survival genes during loss of heterozygosity (LOH) formations which eliminate tumor suppressor genes. The LOHs and structurally abnormal chromosomes present in the aneuploid LoVo (colon), A549 (lung), SUIT-2 (pancreas), and LN-18 (glioma) ca… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
16
0

Year Published

2008
2008
2013
2013

Publication Types

Select...
4
1

Relationship

1
4

Authors

Journals

citations
Cited by 6 publications
(16 citation statements)
references
References 67 publications
(39 reference statements)
0
16
0
Order By: Relevance
“…SNP‐maps can be classified as: (i) heterozygous with red (heterozygous) and blue (homozygous) SNPs along the entire chromosome length, indicating presence of DNA from both parental homologues; (ii) broken‐chromosome LOHs resulting from loss of a large fragment(s) from one parental homologue, with the LOH region (blue dots only) found where the DNA from only one homologue remains; and (iii) whole‐chromosome LOHs, or only a haploid genome of one parental homologue remaining (blue dots only), following complete loss of the other parental homologue (Fig. 2) (15). The occasional heterozygous SNPs (red dots) found in whole‐chromosome SNP‐maps may be due to assay errors or to represent small, translocated DNA pieces from opposing parental homologues.…”
Section: Resultsmentioning
confidence: 99%
See 3 more Smart Citations
“…SNP‐maps can be classified as: (i) heterozygous with red (heterozygous) and blue (homozygous) SNPs along the entire chromosome length, indicating presence of DNA from both parental homologues; (ii) broken‐chromosome LOHs resulting from loss of a large fragment(s) from one parental homologue, with the LOH region (blue dots only) found where the DNA from only one homologue remains; and (iii) whole‐chromosome LOHs, or only a haploid genome of one parental homologue remaining (blue dots only), following complete loss of the other parental homologue (Fig. 2) (15). The occasional heterozygous SNPs (red dots) found in whole‐chromosome SNP‐maps may be due to assay errors or to represent small, translocated DNA pieces from opposing parental homologues.…”
Section: Resultsmentioning
confidence: 99%
“…Four prostate cancer cell lines (DU‐145, PC‐3, 22Rv1, LNCap), a benign prostate cell line (RWPE), three lung cancer cell lines (A549, H520, Calu‐6), two benign lung fibroblast lines (CCD‐34Lu, MRC‐5), a pancreatic cancer cell line (SUIT‐2) and a benign skin cell line (BUD‐8) made up the 12 experimental cell lines used. Each of the cell lines was obtained from the American Type Culture Collection (http://www.atcc.org), except for SUIT‐2, which had been previously characterized (15). All cell lines were expanded as monolayer cultures.…”
Section: Methodsmentioning
confidence: 99%
See 2 more Smart Citations
“…Paradoxically, aneuploidy is also often found in cancer cells that have gained growth advantages and divide out of control. The normally deleterious effects of simple aneuploidy (gain or loss of whole chromosomes) in diploid cells are compensated for in cancer cells (Nestor et al, 2007). These compensation mechanisms may include polypoidisation or gross chromosomal structural alterations in addition to specific genetic or epigenetic modifications on oncogenes or tumour suppressors.…”
Section: Diseases and Drugs Affecting Chromosome Segregationmentioning
confidence: 99%